NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Status: Open
- Who can apply
- Small businesses.
- Deadline
- Thursday, April 5, 2029 - check the notice for the exact time
- Opened May 28, 2026
- Amount
- Not stated by the source
- Matching funds required
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- Documents with the official notice: PA-27-101-Revised-Full-Announcement.html
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.233, 93.242, 93.273, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or ...